Domo, Inc.
NASDAQ:DOMOSoftware - Application
+$0.43 today
- Market cap
- $155.39M
- Beta
- 1.77
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$1.28
Volume 3.18M
Average 1.39M
DOMO Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Domo, Inc.NASDAQ: DOMO
Investing Cash Flow · Q1 FY2027 · quarter ended Apr 2026
Investing cash flow declines year over year
Q1 FY2027 investing cash flow of $1.86M (cash outflow) fell 36.6% year over year, behind the -9.8% change in trailing-twelve-month investing cash flow. Sequentially, it fell 22.3% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.
Context
- Investing cash flow amounted to 3.1% of revenue in FY2026, up 0.1 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -36.6% toward the trailing-twelve-month pace of -9.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2026
- (9.95M) USD
- Year-over-year change
- -5.4%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | (9.95M) | -5.4% |
| FY2025 | 2025-01-31 | (9.45M) | +19.7% |
| FY2024 | 2024-01-31 | (11.76M) | -47.1% |
| FY2023 | 2023-01-31 | (8M) | -22.7% |
| FY2022 | 2022-01-31 | (6.52M) | — |
Investing Cash Flow vs competitors
How DOMO compares with its peers on the latest reported figures
- Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -9.8% is the 5th highest of 10, against a peer median of -51.9%.
- Investing cash flow amounts to 2.8% of revenue for DOMO, versus a peer median of 5.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $54.64M USD | -347.6% | +11.4% | 11.6% | |
| LTM Mar 2026 | $30.62M USD | +5.0% | -11.3% | 5.4% | |
| LTM Mar 2026 | $18.92M USD | +443.3% | -30.0% | 12.6% | |
| LTM Mar 2026 | $14.14M USD | -382.2% | -49.8% | 5.7% | |
| LTM Mar 2026 | $12.67M USD | -51.9% | -48.6% | 1.4% | |
| LTM Mar 2026 | $9.75M USD | -403.9% | -0.0% | 3.2% | |
| LTM Apr 2026 | $8.88M USD | -9.8% | +7.6% | 2.8% | |
| FY2025 | $683K USD | +128.5% | — | 128.9% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥360.38K CNY | — | -38.8% | — |
| LTM Mar 2026 | $243K USD | -99.0% | +16.9% | 0.6% | |
| LTM Mar 2026 | $22K USD | +0.0% | -94.0% | 0.0% | |
| Peer median (excluding DOMO) | — | -51.9% | -30.0% | 5.4% | |
Competitors are the stored peer set for DOMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (102.11M) | (105.55M) | (75.57M) | (81.94M) | (59.34M) |
| Depreciation & Amortization | 10.2M | 10.02M | 24.39M | 26.76M | 9.84M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 56.06M |
| Change in Working Capital | 12.31M | (22.93M) | (19.64M) | (25.85M) | (23.52M) |
| Accounts Receivables | (15.88M) | (14.81M) | 11.76M | (4.35M) | (13.91M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.76M | 6.95M | (6.97M) | 1.83M | 8.88M |
| Other Working Capital | 24.43M | (15.06M) | (24.43M) | (23.33M) | (18.49M) |
| Other Non-Cash Items | 79.98M | 107.57M | 73.4M | 71.97M | 24.9M |
| Operating Cash Flow | 379K | (10.89M) | 2.58M | (9.05M) | 7.93M |
| Capital Expenditures | (6.52M) | (8M) | (11.73M) | (9.45M) | (9.95M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (6.52M) | (8M) | (11.76M) | (9.45M) | (9.95M) |
| Debt Repayment | 0 | 0 | 0 | 3.3M | (6.79M) |
| Common Stock Issued | 9.75M | 2.42M | 3.47M | 1.91M | 1.33M |
| Common Stock Repurchased | (10.32M) | 0 | 0 | (820K) | (3.25M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | (1M) | 6.5M |
| Financing Cash Flow | (561K) | 2.42M | 3.47M | 3.39M | (2.2M) |
| Effect of Forex Changes | (534K) | (599K) | 145K | (569K) | 1.91M |
| Net Change in Cash | (7.23M) | (17.06M) | (5.56M) | (15.68M) | (2.31M) |
| Free Cash Flow | (6.14M) | (18.89M) | (9.15M) | (18.5M) | (2.02M) |
Domo, Inc.
NASDAQ:DOMO
Intrinsic Alpha fair value
Locked
Current Price
$3.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.